Search for Clinical Trial Results

Sponsored By

Shwachman-Diamond Syndrome - 13 Studies Found

Status Study
Completed Study Name: Stem Cell Transplant for Bone Marrow Failure Syndromes
Condition:
  • Diamond-Blackfan Anemia
  • Kostmann's Neutropenia
  • Date: 2005-09-12
    Interventions:
    • Procedure: Stem cell transplant

Completed Study Name: Phase II Pilot Study of Granulocyte Colony-Stimulating Factor for Inherited Bone Marrow Failure Syndromes
Condition:
  • Shwachman Syndrome
  • Fanconi's Anemia
  • Dyskeratosis Congenita
  • Fanconi Anemia
  • Myelodysplastic Synd
    Date: 2007-07-10
    Interventions:
    • Genetic: polymerase chain reaction
    • Other:

Active, not recruiting Study Name: Stem Cell Transplant for Hemoglobinopathy
Condition:
  • Sickle Cell Disease
  • Thalassemia
  • Severe Congenital Neutrope
    Date: 2005-09-12
    Interventions:
    • Drug: Busulfan, Fludarabine, ATG, TLI

Recruiting Study Name: Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies
Condition:
  • Sickle Cell Disease
  • Transfusion Dependent Alpha- or Beta- Thalassemia
  • Drug: Reduced Toxicity Ablative Regimen

Recruiting Study Name: BMT Abatacept for Non-Malignant Diseases
Condition:
  • Hurler Syndrome
  • Fanconi Anemia
  • Glanzmann Thrombasthenia Date: 2013-07-24
    Interventions: Drug: Abatacept All patients will receive 4 doses of abatacept in addition to standard GVHD prophylaxis
Active, not recruiting Study Name: Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Condition:
  • Accelerated Phase Chronic Myelogenous Leukemia
  • Adult Acute Lymphoblastic Leukemia in Remissi
    Date: 2012-02-06
    Interventions:
    • Drug: fludarabine phosphate Gi
Recruiting Study Name: CD34+ Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation for Non-Malignant Disease
Condition:
  • Bone Marrow Failure Syndrome
  • Severe Aplastic Anemia
  • Severe
    Date: 2013-10-17
    Interventions: Biological: CD34 Stem Cell Selection Therapy The CliniMacs (PLUS) Reagent System (Miltenyi CliniMacs CD3
Suspended Study Name: Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation
Condition:
  • Thalassemia
  • Sickle Cell Disease
  • Glanzmann Thrombasthenia Date: 2010-09-15
    Interventions: Drug: Alefacept 0.25 mg/kg IV on day -40 and day -39 0.5 mg/kg IV on days -33, -26, -19 and -12 Alefacep
Recruiting Study Name: Cancer in Inherited Bone Marrow Failure Syndromes
Condition:
  • Aplastic Anemia
  • Head and Neck Neoplasms
  • Bone Marrow Failur
    Date: 2001-11-29
Next >>>